Business Wire
05 Oct 2026, 04:00 UTC · 2h ago
Impact · against what's priced in
MedX Health gains a foothold in the European beauty and aesthetics research market via a sales partnership with Monaderm. This establishes a new potential revenue stream for the company's SkinSecure™ technology.
No priced-in read yet
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
MedX Health appointed Monaderm as its European sales representative for SkinSecure™ within the beauty and aesthetics research sectors.
Newannounced today via Business Wire
So whatExpansion into the European cosmetics market provides a new revenue stream for FY2027.
More positive than 78% of claims this week
Which stocks this story touches
Continue reading
5 related stories
The appointment of Monaderm as a European sales agent opens a new commercial channel for SkinSecure™ in the cosmetics and skin research sectors, diversifying the company's geographic revenue base.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 88% of ticker scores this week
The company is expanding its commercial reach in Europe through a new strategic sales partnership.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
5h ago
—
No price for MDX right now — the quote feed didn't answer.
MDX chart →
